← back to search

Lei Miao

University of North Carolina at Chapel Hill · US
🔎 Find collaborators in Molecular Biology · Immunology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Immunology
Research interest
Research interests include RNA Interference and Gene Delivery, Advanced biosensing and bioanalysis techniques, Immunotherapy and Immune Responses, and Lipid Membrane Structure and Behavior.
h-index
21
citations
5,367
works
47
NIH funding
primary concept
email

Recent publications

Peptide codes for organ-selective mRNA delivery
Nature Materials 2025cited by 18position: middledoi
The drug-elicitable alternative splicing module for tunable vector expression in the heart
Nature Cardiovascular Research 2025cited by 8position: middledoi
Patchoulene epoxide mitigates colitis and hepatic damage induced by dextran sulfate sodium by regulating the colonic microbiota and purine metabolism
Frontiers in Immunology 2025cited by 4position: middledoi
RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment
Nature Communications 2024cited by 32position: lastdoi
mRNA vaccine for cancer immunotherapy
Molecular Cancer 2021cited by 891position: firstdoi
Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver
Nature Communications 2020cited by 327position: firstdoi
Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy
Science Translational Medicine 2020cited by 187position: middledoi
Understanding the synergistic effect of physicochemical properties of nanoparticles and their cellular entry pathways
Communications Biology 2020cited by 105position: middledoi
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
Molecular Therapy 2019cited by 1,074position: middledoi
Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation
Nature Biotechnology 2019cited by 694position: firstdoi
Nanoparticle cancer vaccines: Design considerations and recent advances
Asian Journal of Pharmaceutical Sciences 2019cited by 110position: middledoi
Nanoformulations for combination or cascade anticancer therapy
Advanced Drug Delivery Reviews 2017cited by 176position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Daniel G. Anderson · Massachusetts Institute of Technology4 papers (2019–2020)Jiaqi Lin · Massachusetts Institute of Technology3 papers (2019–2020)Yuxuan Huang · Massachusetts Institute of Technology3 papers (2019–2020)Derfogail Delcassian · Massachusetts Institute of Technology3 papers (2019–2024)Kaitlyn Sadtler · National Institutes of Health2 papers (2019–2020)Xueguang Lu · Massachusetts Institute of Technology2 papers (2020–2024)Yunhua Shi · Massachusetts Institute of Technology2 papers (2019–2020)Leaf Huang · University of North Carolina at Chapel Hill2 papers (2017–2021)Róbert Langer · Laboratoire d’immunologie intégrative du cancer2 papers (2019–2020)Linxian Li · Chinese University of Hong Kong2 papers (2019–2020)Yifan Ge · Nantong University2 papers (2020–2024)Wenting Gao · Hubei University of Medicine2 papers (2019–2020)Ziqi Chen · Massachusetts Institute of Technology1 papers (2020–2020) · 1 papers (2025–2025)Zhiqiang Zhao · Tianjin University of Traditional Chinese Medicine1 papers (2024–2024)Jinsong Han · China Pharmaceutical University1 papers (2019–2019)Chih-Hsin Lin · Institute of Atomic and Molecular Sciences, Academia Sinica1 papers (2020–2020) · 1 papers (2025–2025)Lemin Zheng · Putian University1 papers (2025–2025)Jing Zhou · Jiangsu University1 papers (2025–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Immunology →